Electronic brachytherapy for superficial and nodular basal cell carcinoma: A report of two prospective pilot trials using different doses

Journal of Contemporary Brachytherapy

Volumn 8, Issue 1, 2016, Pages 48-55

  Ballester Sánchez, Rosa ^a   Pons Llanas, Olga ^a   Candela Juan, Cristian ^a   Celada Álvarez, Francisco Javier ^a   Barker, Christopher A ^b   Tormo Micó, Alejandro ^a   Pérez Calatayud, Jose ^a,c   Botella Estrada, Rafael ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Hospital Clínica Benidorm   (Spain)

Author keywords

Basal cell carcinoma; Electronic brachytherapy; Radiation therapy; Skin cancer

Indexed keywords

AGED; ARTICLE; BASAL CELL CARCINOMA; BRACHYTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NODULAR BASAL CELL CARCINOMA; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION HAZARD; SUPERFICIAL BASAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 84959553095     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2016.57531     Document Type: Article

References (40)

1. Lear W, Dahlke E, Murray CA. Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg 2007; 11: 19-30.
2. Roozeboom MH, Arits AH, Nelemans PJ et al. Overall treatments success after treatment of primary superficial basal cell carcinoma: A systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 2012; 167: 733-756.
3. Candela-Juan C, Niatsetski Y, Ouhib Z et al. Commissioning and periodic tests of the Esteya® electronic brachytherapy system. J Contemp Brachytherapy 2015; 7: 189-195.
4. th annual meeting of the American Academy of Dermatology; 2015 March 20-24; San Francisco, USA.
5. th annual meeting of the American Academy of Dermatology; 2015 March 20-24; San Francisco, USA.
6. th annual meeting of the American Academy of Dermatology; 2015 march 20-24; San Francisco, USA.
7. Paravati AJ, Hawkins PG, Martin AN et al. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer. Pract Radiat Oncol 2015; 5: 659-664.
8. Linos E, Van Beek M, Resneck JS. A sudden and concerning increase in the use of electronic brachytherapy for skin cancer. JAMA Dermatol 2015; 151: 699-700.
9. Ouhib Z, Kasper M, Perez Calatayud J et al. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy 2015; 14: 840-858.
10. Tormo A, Celada F, Rodriguez S et al. Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy 2014; 6: 167-172.
11. Jones B, Dale RG, Deehan C et al. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 2001; 13: 71-81.
12. Onishi H, Araki T, Shirato H et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer 2004; 101: 1623-1631.
13. Pötter R, Haie-Meder C, van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, and radiobiology. Radiother Oncol 2006; 78: 67-77.
14. Trott KR, Maciejewski B, Preuss-Bayer G et al. Dose-response curve and split-dose recovery in human skin cancer. Radiother Oncol 1984; 2: 123-129.
15. Pons-Llanas O, Ballester-Sánchez R, Celada-Álvarez FJ et al. Clinical implementation of a new electronic brachytherapy system for skin brachytherapy. J Contemp Brachytherapy 2014; 6: 417-423.
16. Food and Drug Administration (FDA). Avoidance of serious x-ray-induced skin injuries to patients during fluoroscopically-guided procedures. Fed Regist 1994; 59: 26402-26405.
17. Reniers B, Liu D, Rusch T et al. Calculation of relative effectiveness of a low-energy electronic brachytherapy source. Phys Med Biol 2008; 53: 7125-7135.
18. Bistrović M, Bišćan M, Viculin T. RBE of 20 kV and 70 kV X-rays determined for survival of V 79 cells. Radiother Oncol 1986; 7: 175-180.
19. Brenner DJ, Leu CS, Beatty JF et al. Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices. Phys Med Biol 1999; 44: 323-333.
20. Verhaegen F, Reniers B. Microdosimetric analysis of various mammography spectra: lineal energy distributions and ionization cluster analysis. Radiat Res 2004; 162: 592-599.
21. 60Co gamma rays. Radiat Res 2005; 164: 669-676.
22. Mestres M, Caballín MR, Barrios L et al. RBE of X rays of different energies: a cytogenetic evaluation by FISH. Radiat Res 2008; 170: 93-100.
23. Bernal MA, de Almeida CE, David M et al. Estimation of the RBE of mammography-quality beams using a combination of a Monte Carlo code with a B-DNA geometrical model. Phys Med Biol 2011; 56: 7393-7403.
24. Flickinger JC. A radiobiological analysis of multicenter data for postoperative keloid radiotherapy. Int J Radiat Oncol Biol Phys 2011; 79: 1164-1170.
25. García-Martínez T, Chan JP, Perez-Calatayud J et al. Dosimetric characteristics of a new unit for electronic skin brachytherapy. J Contemp Brachytherapy 2014; 6: 45-53.
26. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
27. Ballester-Sánchez R, Pons-Llanas O, Llavador-Ros M et al. Depth determination of skin cancers treated with superficial brachytherapy: ultrasound vs histopathology. J Contemp Brachytherapy 2014; 6: 356-361.
28. Ballester-Sánchez R, Pons-Llanas O, Pérez-Calatayud J et al. Dermoscopy margin delineation in radiotherapy planning for superficial or nodular basal cell carcinoma. Br J Dermatol 2014; 172: 1162-1163.
29. CTCAE v4.0: NIH Publication No. 09-5410.
30. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
31. Bath-Hextall FJ, Perkins W, Bong J et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2007; 24: CD003412.
32. Avril MF, Auperin A, Margulis A et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-106.
33. Delishaj D, Manfredi B, Laliscia C et al. Non-melanoma skin cancer treated with HDR Brachytherapy and Valencia applicator in elderly patients. Eur J Cancer 2015; 51: S669.
34. Ballester-Sánchez R, Pons-Llanas O, Candela-Juan C et al. Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma. J Contemp Brachytherapy 2015; 7: 231-238.
35. Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013; 12: 134-140.
36. Ghaly M, Zinkin H, Dannenberg M et al. HDR brachytherapy with standardized surface applicators in the treatment of superficial malignant skin lesions. Int J Radiat Oncol Biol Phys 2008; 72: 505-506.
37. Gauden S, Egan C, Pracy M. HDR brachytherapy for the treatment of the skin cancer using standard surface applicators. Brachytherapy 2008; 7: S159.
38. Amendola BE, Amendola MA, Fowler J. Dermatological applications of HDR using surface applicators using a shorter treatment schedule. Brachytherapy 2006; 5: S106.
39. Fabrini MG, Perrone F, De Liguoro M et al. High dose rate brachytherapy in a large squamous cell carcinoma of the hand. Brachytherapy 2008; 7: 270-275.
40. Kohler-Brock A, Prager W, Pohlmann S et al. The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig Applicator). Strahlenther Onkol 1999; 175: 170-174.